Committed to developing
We are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology.
Join a dynamic team dedicated to making a difference
Our mission and passion for what we do are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture.
Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine
Feb 28, 2023